Stay updated on Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check7 days agoChange DetectedA site-wide NIH notice announces updates to NIH websites and says “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s site revision identifier advances from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the prior study content with an access-restricted message. This means the study record cannot be viewed until access is restored.SummaryDifference20%

- Check63 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page. This indicates a minor update to the study record version rather than a change to the clinical content.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the record. This update is a metadata/version change and does not modify the study content or outcomes.SummaryDifference0.1%

Stay in the know with updates to Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.